The European Medical Agency (EMA) declared the AstraZeneca COVID-19 vaccine to be “safe and effective,” with the benefits of it outweighing the risks following an investigation into reports of blood clots that prompted more than a dozen countries to suspend its use.
However, the drug regulator said they will update their guidance to include an explanation about the potential risks for doctors and the public since they could not rule out definite a link between individual reported cases of blood clots and the vaccine..